Well-promising outcomes with a novel drug nanocarrier for the targeted therapy in cancer treatment
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-054-Tuesday
- By: SONG, Yunmei (university of south Australia, Adelaide, Australia)
- Co-author(s): Yunmei Song: School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
Naxin Ma: School of Pharmaceutical Science, Shandong University, Jinan, China
Jing Liu: School of Pharmaceutical Science, Shandong University, Jinan, China
Wenxiu He: School of Pharmaceutical Science, Shandong University, Jinan, China
Zhonghao Li: Key Lab of Colloid & Interface Chemistry, Shandong University, Jinan, China
Yuxia Luan: School of Pharmaceutical Science, Shandong University, Jinan, China
Sanjay Garg: School of Pharmacy and Medical Sciences, university of south Australia, Adelaide, Australia - Abstract:
Backgrounds
The development of novel targeting nano-carriers for the delivery of anticancer drugs to tumor cells has achieved promising outcomes in the pharmaceutical field. In the present study, a novel hybrid material as an anticancer drug carrier was designed and prepared with folic acid-grafted bovine serum albumin decorated graphene oxide.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023